Format
Sort by
Items per page

Send to

Choose Destination

Links from PubMed

Items: 1 to 20 of 21

1.

Detection of circulating tumor cells with CK20 RT-PCR is an independent negative prognostic marker in colon cancer patients - a prospective study.

Hinz S, Hendricks A, Wittig A, Schafmayer C, Tepel J, Kalthoff H, Becker T, Röder C.

BMC Cancer. 2017 Jan 13;17(1):53. doi: 10.1186/s12885-016-3035-1.

2.

Ki-67 Expression in CRC Lymph Node Metastasis Does Not Predict Survival.

Martins SF, Amorim R, Mota SC, Costa L, Pardal F, Rodrigues M, Longatto-Filho A.

Biomed Res Int. 2015;2015:131685. doi: 10.1155/2015/131685. Epub 2015 Sep 13.

3.

Early stage colon cancer.

Freeman HJ.

World J Gastroenterol. 2013 Dec 14;19(46):8468-73. doi: 10.3748/wjg.v19.i46.8468. Review.

4.

What is the optimal means of staging colon cancer?

Arena EA, Bilchik AJ.

Adv Surg. 2013;47:199-211. Review.

5.

The association between CD166 detection rate and clinicopathologic parameters of patients with colorectal cancer.

Shafaei S, Sharbatdaran M, Kamrani G, Khafri S.

Caspian J Intern Med. 2013 Fall;4(4):768-72.

6.

Adequacy of lymph node examination in colorectal surgery: contribution of the hospital versus the surgeon.

Rhoads KF, Ackerson LK, Ngo JV, Gray-Hazard FK, Subramanian SV, Dudley RA.

Med Care. 2013 Dec;51(12):1055-62. doi: 10.1097/MLR.0b013e3182a53d72.

7.

Colorectal cancer biomarkers and the potential role of cancer stem cells.

Langan RC, Mullinax JE, Raiji MT, Upham T, Summers T, Stojadinovic A, Avital I.

J Cancer. 2013;4(3):241-50. doi: 10.7150/jca.5832. Epub 2013 Mar 15.

8.

Evidence-based Guidelines for Precision Risk Stratification-Based Screening (PRSBS) for Colorectal Cancer: Lessons learned from the US Armed Forces: Consensus and Future Directions.

Avital I, Langan RC, Summers TA, Steele SR, Waldman SA, Backman V, Yee J, Nissan A, Young P, Womeldorph C, Mancusco P, Mueller R, Noto K, Grundfest W, Bilchik AJ, Protic M, Daumer M, Eberhardt J, Man YG, Brücher BL, Stojadinovic A.

J Cancer. 2013;4(3):172-92. doi: 10.7150/jca.5834. Epub 2013 Mar 1.

9.

A Pilot Study Assessing the Potential Role of non-CD133 Colorectal Cancer Stem Cells as Biomarkers.

Langan RC, Mullinax JE, Ray S, Raiji MT, Schaub N, Xin HW, Koizumi T, Steinberg SM, Anderson A, Wiegand G, Butcher D, Anver M, Bilchik AJ, Stojadinovic A, Rudloff U, Avital I.

J Cancer. 2012;3:231-40. doi: 10.7150/jca.4542. Epub 2012 Jun 1.

10.

Analysis of sentinel lymph node biopsy results in colon cancer in regard of the anthropometric features of the population and body composition assessment formulas.

Nowaczyk P, Murawa D, Połom K, Waszyk-Nowaczyk M, Spychała A, Michalak M, Murawa P.

Langenbecks Arch Surg. 2012 Jun;397(5):779-86. doi: 10.1007/s00423-012-0938-4. Epub 2012 Mar 14.

11.

Role of endoglin and VEGF family expression in colorectal cancer prognosis and anti-angiogenic therapies.

Martins SF, Reis RM, Rodrigues AM, Baltazar F, Filho AL.

World J Clin Oncol. 2011 Jun 10;2(6):272-80. doi: 10.5306/wjco.v2.i6.272.

12.

The Feasibility of an Ex-vivo Sentinel Lymph Mapping Using Preoperative Radioisotope Injection in Cases of Extraperitoneal Rectal Cancer.

Park JS, Choi GS, Kim HJ, Park SY, Park YJ, Lee SW, Xu Z, Bae HI.

J Korean Soc Coloproctol. 2011 Apr;27(2):83-9. doi: 10.3393/jksc.2011.27.2.83. Epub 2011 Apr 30.

13.

The influence of micrometastases on prognosis and survival in stage I-II colon cancer patients: the Enroute⊕ Study.

Lips DJ, Koebrugge B, Liefers GJ, van de Linden JC, Smit VT, Pruijt HF, Putter H, van de Velde CJ, Bosscha K.

BMC Surg. 2011 May 11;11:11. doi: 10.1186/1471-2482-11-11.

14.

Sentinel node biopsy in colorectal cancer: Must we believe it?

Scabini S.

World J Gastrointest Surg. 2010 Jan 27;2(1):6-8. doi: 10.4240/wjgs.v2.i1.6.

15.

Clinical translation of ex vivo sentinel lymph node mapping for colorectal cancer using invisible near-infrared fluorescence light.

Hutteman M, Choi HS, Mieog JS, van der Vorst JR, Ashitate Y, Kuppen PJ, van Groningen MC, Löwik CW, Smit VT, van de Velde CJ, Frangioni JV, Vahrmeijer AL.

Ann Surg Oncol. 2011 Apr;18(4):1006-14. doi: 10.1245/s10434-010-1426-0. Epub 2010 Nov 16.

16.

Surgical quality and nodal ultrastaging is associated with long-term disease-free survival in early colorectal cancer: an analysis of 2 international multicenter prospective trials.

Bilchik A, Nissan A, Wainberg Z, Shen P, McCarter M, Protic M, Howard R, Elashoff D, Tyler J, Peoples GE, Stojadinovic A.

Ann Surg. 2010 Sep;252(3):467-74; discussion 474-6. doi: 10.1097/SLA.0b013e3181f19767.

17.

Prognostic relevance of occult nodal micrometastases and circulating tumor cells in colorectal cancer in a prospective multicenter trial.

Koyanagi K, Bilchik AJ, Saha S, Turner RR, Wiese D, McCarter M, Shen P, Deacon L, Elashoff D, Hoon DS.

Clin Cancer Res. 2008 Nov 15;14(22):7391-6. doi: 10.1158/1078-0432.CCR-08-0290.

18.
19.

Evolving management of colorectal cancer.

van der Voort van Zijp J, Hoekstra HJ, Basson MD.

World J Gastroenterol. 2008 Jul 7;14(25):3956-67. Review.

20.

What's wrong with sentinel node mapping in colon cancer?

Cahill RA.

World J Gastroenterol. 2007 Dec 21;13(47):6291-4. Review.

Supplemental Content

Support Center